Report

|

February 26, 2024

How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.

Appendix: Detailed chart and tables

By Alec Tyson and Emma Kikuchi

Table of Contents

Bar chart showing that a majority of Americans across demographic groups have heard at least a little about Ozempic, Wegovy and other similar drugs. Just 25% of U.S. adults have heard nothing at all.

Table showing Americans’ views of Ozempic, Wegovy and other similar drugs as options for weight loss. Across demographic groups, Americans are far more likely to say these drugs are good options for people with obesity or a weight-related health condition than for those with no such condition who just want to lose weight.

1 2 3 4

Next Page →

Topics

Most Popular

Report Materials

Table of Contents